From developing intensive care equipment to tackling supplies of PPE and oxygen, here's how a group of Cambridge researchers refocused and partnered with local hospitals during COVID-19.
Cambridge scientists have identified a drug that can be repurposed to prevent COVID-19 in research involving a unique mix of ‘mini-organs’, donor organs, animal studies and patients.
A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a UK-wide trial, led by Addenbrooke’s Hospital and the University of Cambridge has found.
The Ukrainian medical students who received essential training at Cambridge University over the summer will take the specialist skills they have learned back home following a 7-week programme of clinical placements.
University of Cambridge is partnering with Kharkiv National Medical University to provide expert teaching and support the Ukrainian health and education systems.
Women who will develop potentially life-threatening disorders during pregnancy can be identified early when hormone levels in the placenta are tested, a new study has shown.
Scientists have used a technique to grow bile duct organoids – often referred to as ‘mini-organs’ – in the lab and shown that these can be used to repair damaged human livers. This is the first time that the technique has been used on human organs.
Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.